Advisors Asset Management’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-151
| Closed | -$1.7K | – | 1456 |
|
|
2025
Q4 | $1.7K | Buy |
151
+3
| +2% | +$34 | ﹤0.01% | 1410 |
|
|
2025
Q3 | $1.71K | Hold |
148
| – | – | ﹤0.01% | 1427 |
|
|
2025
Q2 | $1.81K | Sell |
148
-3
| -2% | -$38 | ﹤0.01% | 1441 |
|
|
2025
Q1 | $2.16K | Sell |
151
-25
| -14% | -$390 | ﹤0.01% | 1457 |
|
|
2024
Q4 | $2.8K | Buy |
+176
| New | +$3.48K | ﹤0.01% | 1440 |
|
|
2020
Q4 | – | Sell |
-51
| Closed | -$2K | – | 1513 |
|
|
2020
Q3 | $2K | Sell |
51
-4
| -7% | -$128 | ﹤0.01% | 1513 |
|
|
2020
Q2 | $2K | Hold |
55
| – | – | ﹤0.01% | 1517 |
|
|
2020
Q1 | $1K | Sell |
55
-1
| -2% | -$30 | ﹤0.01% | 1470 |
|
|
2019
Q4 | $2K | Sell |
56
-3
| -5% | -$109 | ﹤0.01% | 1520 |
|
|
2019
Q3 | $2K | Hold |
59
| – | – | ﹤0.01% | 1537 |
|
|
2019
Q2 | $3K | Sell |
59
-2
| -3% | -$86 | ﹤0.01% | 1511 |
|
|
2019
Q1 | $3K | Hold |
61
| – | – | ﹤0.01% | 1781 |
|
|
2018
Q4 | $3K | Sell |
61
-2
| -3% | -$105 | ﹤0.01% | 1556 |
|
|
2018
Q3 | $4K | Sell |
63
-1
| -2% | -$64 | ﹤0.01% | 1543 |
|
|
2018
Q2 | $4K | Sell |
64
-1
| -2% | -$53 | ﹤0.01% | 1549 |
|
|
2018
Q1 | $3K | Hold |
65
| – | – | ﹤0.01% | 1492 |
|
|
2017
Q4 | $3K | Sell |
65
-3
| -4% | -$138 | ﹤0.01% | 1480 |
|
|
2017
Q3 | $3K | Hold |
68
| – | – | ﹤0.01% | 1482 |
|
|
2017
Q2 | $3K | Sell |
68
-8
| -11% | -$302 | ﹤0.01% | 1538 |
|
|
2017
Q1 | $3K | Sell |
76
-1,100
| -94% | -$42.9K | ﹤0.01% | 1527 |
|
|
2016
Q4 | $43K | Sell |
1,176
-3
| -0.3% | -$107 | ﹤0.01% | 1727 |
|
|
2016
Q3 | $41K | Sell |
1,179
-100
| -8% | -$3.5K | ﹤0.01% | 1726 |
|
|
2016
Q2 | $42K | Sell |
1,279
-77
| -6% | -$2.36K | ﹤0.01% | 1714 |
|
|
2016
Q1 | $39K | Sell |
1,356
-292
| -18% | -$7.78K | ﹤0.01% | 1670 |
|
|
2015
Q4 | $55K | Sell |
1,648
-2,565
| -61% | -$79.8K | ﹤0.01% | 1690 |
|
|
2015
Q3 | $120K | Sell |
4,213
-2,848
| -40% | -$99.3K | ﹤0.01% | 1479 |
|
|
2015
Q2 | $286K | Sell |
7,061
-4,290
| -38% | -$193K | ﹤0.01% | 1283 |
|
|
2015
Q1 | $558K | Sell |
11,351
-5,608
| -33% | -$260K | 0.01% | 1055 |
|
|
2014
Q4 | $771K | Buy |
+16,959
| New | +$666K | 0.01% | 934 |
|
Other funds holding AVNS
AC
VCM
VPM
Advisors Asset Management's AVNS Position: Q1 2026 in Review
Advisors Asset Management sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 151 shares — an estimated $1.7K sold.
Advisors Asset Management first reported a position in AVNS in Q4 2014 and held it in 29 quarters. The position peaked at $771K in Q4 2014. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.
- Advisors Asset Management reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
- Advisors Asset Management sold 151 Avanos Medical shares in Q1 2026, an estimated $1.7K.
- Advisors Asset Management first reported a position in Avanos Medical in Q4 2014 and held it in 29 quarters.
- Advisors Asset Management's Avanos Medical position peaked at $771K in Q4 2014.
- 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.
Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.